Characterization of A-kinase-anchoring disruptors using a solution-based assay

Area of Science:

• Biochemistry
• Molecular Biology
• Cell Biology

Background:

• Subcellular localization of protein kinase A (PKA) relies on regulatory (R) subunits binding to A-kinase-anchoring proteins (AKAPs).
• Understanding these interactions is crucial for deciphering PKA signaling pathways and cellular functions.

Purpose of the Study:

• To develop and validate the Amplified Luminescent Proximity Homogeneous Assay (AlphaScreen) for characterizing AKAP-based peptide competitors of PKA anchoring.
• To assess the efficacy of known anchoring disruptors and novel peptides in competing with PKA subunit binding to AKAPs.

Main Methods:

• Utilized AlphaScreen technology to quantify the binding affinities (IC50 values) of peptide competitors to PKA regulatory subunits (RIalpha and RIIalpha) and AKAPs.
• Investigated the competitive inhibition of PKA-AKAP complex formation by various anchoring disruptors.
• Analyzed the kinetics of PKA subunit displacement from pre-formed PKA-AKAP complexes.

Main Results:

• The prototypic disruptor Ht31 efficiently competed with RIIalpha binding to RII-specific and dual-specificity AKAPs (IC50: 1.4±0.2 nM and 6±1 nM).
• RIalpha isoform binding was less efficiently competed by Ht31 (IC50: 156±10 nM).
• RIAD (IC50: 13±1 nM) was a more potent RI-selective disruptor than PV-38 (IC50: 304±17 nM) and did not affect RIIalpha-AKAP interactions.
• Kinetic differences in RII displacement versus complex formation competition were observed for Ht31, unlike RIalpha-AKAP complexes.

Conclusions:

• AlphaScreen is a robust and sensitive assay for characterizing PKA-AKAP interactions and evaluating AKAP-based peptide competitors.
• The assay provides quantitative data on the potency and selectivity of anchoring disruptors.
• This method holds promise for detailed characterization of diverse PKA-AKAP complexes and their modulation.